A novel pH-sensitive liposome formulation containing oleyl alcohol.

pH-sensitive liposomes are designed to undergo acid-triggered destabilization. First generation pH-sensitive liposomes, based on the cone-shaped lipid dioleoylphosphatidylethanolamine (DOPE), have been shown to lose fusogenicity in the presence of serum. Here, we report the design and evaluation of novel serum-resistant pH-sensitive liposome formulations that are based on the composition of egg phosphatidylcholine (PC), cholesteryl hemisuccinate (CHEMS), oleyl alcohol (OAlc), and Tween-80 (T-80). When loaded with the fluorescent probe calcein, these liposomes exhibited excellent stability at pH 7.4 and underwent rapid destabilization upon acidification as shown by calcein dequenching and particle size increase. Adjusting the mole percentages of T-80 and OAlc in the formulation could regulate the stability and pH-sensitive properties of these liposomes. Liposomes with a higher T-80 content exhibited greater stability but were less sensitive to acid-induced destabilization. Meanwhile, formulations with a higher OAlc content exhibited greater content release in response to low pH. The pH-triggered liposomal destabilization did not produce membrane fusion according to an octadecylrhodamine B chloride (R(18)) lipid-mixing assay. Compared to DOPE-based pH-sensitive liposomes, the above formulations showed much better retention of their pH-sensitive properties in the presence of 10% serum. These liposomes were then evaluated for intracellular delivery of entrapped cytosine-beta-D-arabinofuranoside (araC) in KB human oral cancer cells, which have elevated folate receptor (FR) expression. The FR, which is amplified in many types of human tumors, has been shown to mediate the internalization of folate-derivatized liposomes into an acidic intracellular compartment. FR-targeted OAlc-based pH-sensitive liposomes, entrapping 200 mM araC, showed approximately 17-times greater FR-dependent cytotoxicity in KB cells compared to araC delivered via FR-targeted non-pH-sensitive liposomes. These data indicated that pH-sensitive liposomes based on OAlc, combined with FR-mediated targeting, are promising delivery vehicles for membrane impermeable therapeutic agents.

[1]  P. Low,et al.  Cytotoxicity of momordin-folate conjugates in cultured human cells. , 1992, The Journal of biological chemistry.

[2]  D. Tzemach,et al.  Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. , 1999, Bioconjugate chemistry.

[3]  P. Low,et al.  The Effects of pH and Intraliposomal Buffer Strength on the Rate of Liposome Content Release and Intracellular Drug Delivery , 1998, Bioscience reports.

[4]  R. Brasseur,et al.  Aminoglycoside antibiotics induce aggregation but not fusion of negatively-charged liposomes. , 1995, European journal of pharmacology.

[5]  L. Huang,et al.  Biodistribution of pH-sensitive immunoliposomes. , 1986, Biochimica et biophysica acta.

[6]  A. Bogdanov,et al.  Destabilization of pH-sensitive liposomes in the presence of human erythrocyte ghosts , 1992 .

[7]  S. Simões,et al.  Sterically Stabilized pH-sensitive Liposomes , 1997, The Journal of Biological Chemistry.

[8]  M. Saraste,et al.  FEBS Lett , 2000 .

[9]  F. Behm,et al.  Folate receptor type β is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia , 1999, Cancer.

[10]  L. Huang,et al.  Small, but not large, unilamellar liposomes composed of dioleoylphosphatidylethanolamine and oleic acid can be stabilized by human plasma. , 1989, Biochemistry.

[11]  J. Ross,et al.  Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications , 1994, Cancer.

[12]  F. Szoka,et al.  pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. , 1984, Biochemistry.

[13]  Lipid polymorphism and the functional roles of lipids in biological membranes. , 1979 .

[14]  F. Szoka,et al.  pH-dependent bilayer destabilization by an amphipathic peptide. , 1987, Biochemistry.

[15]  S. Mohan,et al.  Isolation and purification of a low-molecular-weight skeletal growth factor from human bones. , 1986, Biochimica et biophysica acta.

[16]  D. Hoekstra,et al.  Fluorescence method for measuring the kinetics of fusion between biological membranes. , 1984, Biochemistry.

[17]  D. Papahadjopoulos,et al.  pH‐sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules , 1985, FEBS letters.

[18]  P. Saigo,et al.  Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. , 1993, The American journal of pathology.

[19]  D. Liu,et al.  pH-sensitive, plasma-stable liposomes with relatively prolonged residence in circulation. , 1990, Biochimica et biophysica acta.

[20]  P. Low,et al.  Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. , 1995, Biochimica et biophysica acta.

[21]  A. Paterson,et al.  Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein. , 1997, Blood.

[22]  P. Low,et al.  Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. , 1994, The Journal of biological chemistry.

[23]  L. Huang,et al.  Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. , 1992, Biochimica et biophysica acta.

[24]  J. Boggs,et al.  Effect of hydrogen-bonding and non-hydrogen-bonding long chain compounds on the phase transitin temperatures of phospholipids , 1986 .

[25]  P. Low,et al.  Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells. , 1993, The Biochemical journal.

[26]  Wenjin Guo,et al.  Receptor-Specific Delivery of Liposomes Via Folate-Peg-Chol , 2000 .

[27]  M. Zignani,et al.  Current status of pH-sensitive liposomes in drug delivery. , 2000, Progress in lipid research.

[28]  P. Cullis,et al.  Recent advances in liposomal drug-delivery systems. , 1995, Current opinion in biotechnology.

[29]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[30]  T. Allen.  Long-circulating (sterically stabilized) liposomes for targeted drug delivery. , 1994, Trends in pharmacological sciences.

[31]  Francis C. Szoka,et al.  pH-Sensitive Liposomes , 1994 .

[32]  F. Szoka,et al.  Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture , 1990, Pharmaceutical Research.